Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Wasechek WayneEVP and CFO |  RYNRAYONIER INCOpen-market sale · 10b5-1 plan | SELL | $62K 2,920 sh | Apr 21, 2026 |
| 8 | Lewis BryanDirector, CEO/President |  IDNIntellicheck, Inc.Open-market sale · 10b5-1 plan | SELL | $85K 10.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Priest Brady PatrickCEO of Clover Care Services |  CLOVCLOVER HEALTH INVESTMENTS, CORP. /DETax withholding | F | $79K 36.1K sh | Apr 21, 2026 traded Apr 18, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $117K 2,441 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $806K 1,398 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Lodge-Jarrett JulieEVP, Chf People & Purpose Ofcr |  DKSDICK'S SPORTING GOODS, INC.Gift | G | — 150 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Ames Sophie CExec. Vice President & CHRO |  QBTSD-Wave Quantum Inc.Open-market sale · 10b5-1 plan | SELL | $66K 3,070 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 7 | Llewellyn Lindsay CatherineSEE REMARKS |  LYFTLyft, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 23.7K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Bradbury Robyn LChief Financial Officer |  CNMCore & Main, Inc.Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Binder Kurtis JosephCHIEF FINANCIAL OFFICER |  ARLOArlo Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $380K 25.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Sharma PankajChief Business Officer |  RELYRemitly Global, Inc.Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Riese Phillip JohnDirector | RELYRemitly Global, Inc. Option exercise · 10b5-1 plan | M | $26K 40.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Gibbons Mary LourdesSVP and Chief Legal Officer |  ESNTEssent Group Ltd.Open-market sale · 10b5-1 plan | SELL | $481K 7,628 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Pearson MarkDirector, President and CEO |  EQHEquitable Holdings, Inc.Option exercise · 10b5-1 plan | M | $630K 27.2K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Ganesan SatishSee Remarks |  SYNASYNAPTICS IncTax withholding · 10b5-1 plan | F | $470K 5,862 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS |  AREALEXANDRIA REAL ESTATE EQUITIES, INC.Open-market sale · 10b5-1 plan | SELL | $26K 536 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Garateix Ernie JDirector, Chief Executive Officer |  HRTGHeritage Insurance Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $8,521 300 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Gupta VikramSee Remarks | SYNASYNAPTICS Inc Tax withholding · 10b5-1 plan | F | $443K 5,518 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Modi Rajeev A.SEE REMARKS |  ELANElanco Animal Health IncGrant or award | A | $1,477 62 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $289K 500 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $581K 1,010 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $254K 442 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $589K 1,009 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $573K 983 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $504K 880 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $397K 687 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $284K 488 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $282K 482 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Hoffmann MartinCEO |  ONONOn Holding AGOpen-market sale · 10b5-1 plan | SELL | $152K 4,150 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 3 | Riese Phillip JohnDirector | RELYRemitly Global, Inc. Option exercise · 10b5-1 plan | M | — 40.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 3 | Atkinson NajumaDirector |  MQMarqeta, Inc.Option exercise · 10b5-1 plan | M | — 30.9K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 3 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $13K 416 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 3 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 2 | Wren ChrisVP of Operations |  PLNHPlanet 13 Holdings Inc.Grant or award · 10b5-1 plan | A | — 822.0K sh | Apr 21, 2026 traded Apr 16, 2026 |
| 2 | Bradbury Robyn LChief Financial Officer | CNMCore & Main, Inc. Other acquisition or disposition · 10b5-1 plan | J | — 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 2 | Bradbury Robyn LChief Financial Officer | CNMCore & Main, Inc. Other acquisition or disposition · 10b5-1 plan | J | — 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $139K 238 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $197K 340 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 1 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $6,413 140 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 0 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Option exercise · 10b5-1 plan | M | — 1,168 sh | Apr 21, 2026 traded Apr 17, 2026 |